The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Zhang, Qingli ^a   Zhang, Qinghui ^a   Cong, Hua ^a   Zhang, Xiaoli ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

BRCA1; Gene detection; WWOX

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CHEMISTRY; CHI SQUARE DISTRIBUTION; CHINA; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TUMOR VOLUME; UPREGULATION; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM GRADING; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84871698823     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-181     Document Type: Article

References (22)

1. Wang Q, Zhu W, Xing X. The twenty-year monitoring and analysis of the incidences of female breast cancer deaths and survivals in the Beijing area. Chinese J Oncol 2006, 28:208-210.
2. Meng J, Zhang J. Analysis of the breast cancer data of the young patients. Chin J Clin Oncol 2006, 33:1316-1319.
3. Fan W, Zhen Q. The tumor suppressor gene and human cancer. Molecular oncology 2005, 123. Beijing People's Health Press.
4. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX,a novel WW domain containing protein mapping to human chromosome 16q23. 3-24. 1, a region frequently affected in breast cancer. Cancer Res 2000, 60:2140-2145.
5. Suris-Swartz PJ, Schildkraut JM, Vine MF, Hertz-Picciotto I. Age at dignosis and multiple primary cancer of the breast and ovary. Breast Cancer Res Treat 1996, 41:21-29. 10.1007/BF01807033, 8932873.
6. Awad AT, El-Husseini G, Anwar M, Abu-Nasr A, Anwar AA, Sakr M. Bilateral primary breast cancer; a clinicpathological study of the second primary. InSurg 1996, 81:57-60.
7. Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Rostislav Vyzula Diagnostic Diagnostic Pathology 2012, 7:31.
8. Hutter RVP. The role of the pathologist in breast cancer managemant. Cancer 1990, 66:1363-1364. 10.1002/1097-0142(19900915)66:14+<1363::AID-CNCR2820661411>3.0.CO;2-4, 2205366.
9. Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu L, Liu Z, Zhang T, Zhang X, Dong X, Quan C. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas. Diagn Pathol 2012, 7:33. 10.1186/1746-1596-7-33, 3349567, 22455563.
10. Liu Y, Gan L, Guo J. Clinical and pathological features and prognosis of young breast cancers. Chinese Medicine 2005, 7:952-953.
11. Cai F, Zhao Y, Lu T. Clinical pathological features of young breast. Cancers 2003, 18:511-512.
12. Curigliano G, Rigo R, Colleoni M, Braud FD, Nole F, Formica V. Adjuvant therapy for very young women with breast cancer: response according to biologic and- endorine leatures. Clin Breast Cancer 2004, 65:125-126.
13. Jimor S, AL2sayer H, Heys SD. Breast cancer in women aged 35 and prognosis and survival. J R COLL SURGEDINBURGH 2002, 47:693-694.
14. Chen G, Yang H, Wang L. Diagnosis of clinical and pathological features of young breast cancers. Cancer 2007, 11:55-56.
15. Yan Y, Haas JP, Kim M, Sgagias MK, Cowan KH. BRCA1-induced apoptosis involves in- activation of ERK1/2 activities. J Biol Chem 2002, 277:33422-33430. 10.1074/jbc.M201147200, 12082091.
16. Chen YM, Chen CF, Riley DJ. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1999, 270:789-791.
17. Fu J, Liu C, Ma R. Expression of BRCA1 and Bad in benign and malignant breast lesions. Xinjiang Medical University 2007, 29:292-294.
18. Liu J, Yang H. Expression of the susceptibility genes in breast cancer tissues and its relationship with the clinicopathological data. Chin J Cancer 2003, 13:31-35.
19. Wojdacz TK, Thestrup BB, Overgaard J, Hansen L. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol 2011, 6:116. 10.1186/1746-1596-6-116, 3253685, 22129206.
20. Lv N, Xie X, Ge Q, Lin S, Wang X, Kong Y, Shi H, Xie X, Wei W. Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations. Diagn Pathol 2011, 6:118. 10.1186/1746-1596-6-118, 3248849, 22132735.
21. Nunez MI, Ludes-Meyers JH, Abba MC. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat 2005, 89:99-105. 10.1007/s10549-004-1474-x, 15692750.
22. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and functional interactions between the wwox tumor suppressor protein and the AP-2y transcription factor. Cancer Res 2004, 64:8256-8261. 10.1158/0008-5472.CAN-04-2055, 15548692.